Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Folia Microbiol (Praha) ; 49(1): 31-6, 2004.
Article in English | MEDLINE | ID: mdl-15114862

ABSTRACT

Stable chromium(VI)-sensitive and -tolerant mutants were obtained by induced mutagenesis of Schizosaccharomyces pombe lysine and leucine auxotrophic heterothallic strains 6chr+ and 9chr+. Eleven of them were selected for further studies. Fast transport of 51CrO4(2-) was detected in a representative sensitive mutant, chr-51S, while the tolerant mutant chr1-66T and the parental strain 6chr+ exhibited significantly lower 51CrO4(2-) uptake. The segregation of tetrads of three selected CrVI-tolerant mutants, chr1-66T, chr1-14T and chr2-04T, strongly indicated that tolerance was determined by single mutations. Random spore analysis proved that the mutations of chr1-66T and chr1-14T were allelic and the mutation of mutant chr2-04T was not allelic with the mutation of chr1-66T. Recombinants carrying the ura4D18 selective marker were created for transformation experiments. Two of them (chr1-661T and chr2-046T) can be used to clone and identify the genes responsible for their CrVI tolerance phenotype.


Subject(s)
Chromium/metabolism , Chromium/pharmacology , Drug Resistance, Fungal/genetics , Schizosaccharomyces/genetics , Schizosaccharomyces/metabolism , Alleles , Antifungal Agents/metabolism , Antifungal Agents/pharmacology , Biological Transport , Colony Count, Microbial , Crosses, Genetic , Genes, Dominant , Genes, Fungal , Genetic Complementation Test , Kinetics , Metals/metabolism , Microbial Sensitivity Tests , Mutation , Recombination, Genetic , Schizosaccharomyces/drug effects , Schizosaccharomyces/growth & development , Transformation, Genetic
2.
FEMS Microbiol Lett ; 178(1): 109-15, 1999 Sep 01.
Article in English | MEDLINE | ID: mdl-10483729

ABSTRACT

Lysine and leucine auxotrophic, heterothallic (h+, h-) strains of Schizosaccharomyces pombe were used to obtain chromium (VI)-sensitive and -tolerant mutants by ultraviolet radiation-induced and nitrosoguanidine-induced mutagenesis. The minimal inhibitory concentrations of K2Cr2O7 on YEA media were 225 microM for the wild-type strain CW-6, 125 microM for the sensitive mutant CS-6.51 and 275 microM for the tolerant mutant CT-6.66. The mutants exhibited cross-sensitivity of various patterns to Cd2+, Cu2+, Ni2+, Zn2+ and VO3-(4). Cr(VI) was added to the actively growing cultures and the total chromium (TOCr) content of the cells was determined. The sensitive mutant exhibited a high bioaccumulation ability, with a dry biomass of 810 micrograms g-1 after 30 min, while the tolerant mutant had a significantly lower ability than the wild-type strain. In PIPES buffer, washed, lysine-starved biomasses were treated with 75 microM Cr(VI) and after 2 h, the TOCr and the organically bound chromium (OBCr) were determined. Under these conditions, the sensitive and tolerant mutants had the same TOCr content, 50% of which was OBCr. The wild-type strain exhibited a lower TOCr content than that of its mutants and only 35% of this was OBCr. The Cr(VI)-sensitivity was due to a significantly increased uptake of Cr(VI).


Subject(s)
Chromium/metabolism , Schizosaccharomyces/metabolism , Metals, Heavy/pharmacology , Mutagenesis/drug effects , Mutagenesis/radiation effects , Nitrosoguanidines/pharmacology , Schizosaccharomyces/genetics , Time Factors , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...